“The glufosinate molecule has essentially been a rollercoaster ride the last 12 to 18 months across the globe. What we’re seeing is a huge increase in demand on a global scale for glufosinate,” Sam Knott, Director of U.S. Central Crops for generics player Atticus LLC told AgriBusiness Global.
 
“When countries like China started to phase out paraquat several years ago and Mexico started to ban glyphosate, the industry has had to rely on a broad-spectrum herbicide like glufosinate that has tolerant crops to fill that void.”
 
Spurred by rapid adoption of the glufosinate-enabled traits, compounded by spreading glyphosate resistance, industry experts believe that between 50% and 70% of all soybeans planted in the U.S. in 2021 will confer tolerance to glufosinate. According to Knott, the industry is in a short-term gap between tight supply and skyrocketing demand but that additional supply should come online by mid-2021.
 
“We’re hearing that some of the generic suppliers here in the U.S. that usually source product out of China are struggling to get supply, and part of that is, a lot of (glufosinate) production that used to come to the U.S. in China is being used for their own needs, so a lot less is being exported out of China,” Tom Mudd, UPL Marketing Manager, Corn and Soybean Herbicides said in an interview with AgriBusiness Global.
 
Click Here to read more.